AcelRx Pharmaceuticals, Inc.

Q4 2025 13F Holders

Symbol
TLPH
CUSIP
00444T209
Type
Equity
Class
COM NEW
Num filings
45
Total reported value, excl. options
$23.8 M
Manager Report Date Value ($000) Shares Option Type